최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of molecular liquids, v.190, 2014년, pp.16 - 22
Badran, M.M. , Taha, E.I. , Tayel, M.M. , Al-Suwayeh, S.A.
The aim of this study was to develop and evaluate ultra-fine selfnanoemulsifying drug delivery system (UF-SNEDDS) of meloxicam (MLX) to enhance its transdermal delivery. The preliminary screening was carried out to select SNEDDS components according to type IV lipid based formulations using surfacta...
J. Food Drug Anal. Chang 14 236 2006
Int. J. Pharm. Yuan 321 117 2006 10.1016/j.ijpharm.2006.06.021
Journal of Chromatography B Ji 826 214 2005 10.1016/j.jchromb.2005.08.023
Eur. J. Pharm. Sci. Aranya 48 474 2013 10.1016/j.ejps.2012.12.010
Adv. Drug Deliv. Rev. Williams 56 603 2004 10.1016/j.addr.2003.10.025
Adv. Drug Deliv. Rev. Kalia 56 619 2004 10.1016/j.addr.2003.10.026
Adv. Drug Deliv. Rev. Denet 56 659 2004 10.1016/j.addr.2003.10.027
Adv. Drug Deliv. Rev. Mitragotri 56 589 2004 10.1016/j.addr.2003.10.024
Eur. J. Pharm. Sci. El Maghraby 34 203 2008 10.1016/j.ejps.2008.05.002
Adv. Colloid Interface Sci. Kogan 123 369 2006 10.1016/j.cis.2006.05.014
Colloids Surf. B: Biointerfaces El Maghraby 75 595 2010 10.1016/j.colsurfb.2009.10.003
Nanomedicine Damanjeet 8 618 2012 10.1016/j.nano.2011.08.015
Biomed. Pharmacother. Gursoy 58 173 2004 10.1016/j.biopha.2004.02.001
Nat. Rev. Drug Discov. Porter 6 231 2007 10.1038/nrd2197
Crit. Rev. Ther. Drug Carrier Syst. Singh 26 427 2009 10.1615/CritRevTherDrugCarrierSyst.v26.i5.10
Int. J. Pharm. Villar 431 161 2012 10.1016/j.ijpharm.2012.04.001
J. Control. Release Thomas 160 25 2012 10.1016/j.jconrel.2012.02.027
J. First Mil. Med. Univ. Ye 23 68 2003
Eur. J. Pharm. Sci. Pouton 29 278 2006 10.1016/j.ejps.2006.04.016
Int. J. Pharm. Ehab 285 109 2004 10.1016/j.ijpharm.2004.03.034
Eur. J. Pharm. Biopharm. Shafiq 66 227 2007 10.1016/j.ejpb.2006.10.014
Alsarra, Journal of Molecular Liquids Shakeel 180 89 2013 10.1016/j.molliq.2013.01.008 Ibrahim A
Int. J. Pharm. Nazzal 235 247 2002 10.1016/S0378-5173(02)00003-0
Carbohydr. Polym. Kong 86 837 2011 10.1016/j.carbpol.2011.05.027
Eur. J. Pharm. Sci. Pouton 11 S93 2000 10.1016/S0928-0987(00)00167-6
Drug Deliv. Oh 18 46 2011 10.3109/10717544.2010.509365
Colloids Surf. A Physicochem. Eng. Asp. Gupta 392 145 2011 10.1016/j.colsurfa.2011.09.048
J. Pharm. Pharmacol. Mullertz 62 1622 2010 10.1111/j.2042-7158.2010.01107.x
Pharm. Dev. Technol. Ngawhirunpat 18 798 2013 10.3109/10837450.2011.627871
Int. J. Drug Formul. Res. Kalra 1 359 2010
Drug Dev. Ind. Pharm. Bandivadekar 39 696 2013 10.3109/03639045.2012.687745
Adv. Drug Deliv. Rev. Pouton 60 625 2008 10.1016/j.addr.2007.10.010
Int. J. Pharm. Constantinides 158 57 1997 10.1016/S0378-5173(97)00248-2
Int. J. Pharm. Anton 344 44 2007 10.1016/j.ijpharm.2007.04.027
Colloids Surf. A Physicochem. Eng. Asp. Shweta 392 145 2011 10.1016/j.colsurfa.2011.09.048
Pharm. Res. Tarr 6 40 1989 10.1023/A:1015843517762
Colloids Surf. B: Biointerfaces Hathout 110 254 2013 10.1016/j.colsurfb.2013.05.007
Eur. J. Pharm. Biopharm. Gershanik 50 179 2005 10.1016/S0939-6411(00)00089-8
Walters 1993 Pharmaceutical Skin Penetration Enhancement
J. Korean Pharm. Sci. Cho 35 165 2005
J. Korean Pharm. Sci. Lee 37 167 2007
Int. J. Pharm. Parka 436 652 2012 10.1016/j.ijpharm.2012.07.054
Int. J. Pharm. Chang 338 48 2007 10.1016/j.ijpharm.2007.01.033
Int. J. Pharm. El Maghraby 355 285 2008 10.1016/j.ijpharm.2007.12.022
Pharm. Res. Kemken 9 554 1992 10.1023/A:1015856800653
NIHPA Wang-Feng 123 880 2009
Colloids Surf. B: Biointerfaces Changez 50 18 2006 10.1016/j.colsurfb.2006.03.018
Int. J. Pharm. Yuan 321 117 2006 10.1016/j.ijpharm.2006.06.021
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.